Answers are grounded in this paper and cite their sources.
Background: Chronic obstructive pulmonary disease (COPD) and lung function are highly heritable, but for most genome-wide association study (GWAS) loci, the effector gene and the lung cell type in which it acts are unknown. Single-cell expression quantitative trait loci (eQTLs) offer a way to resolve the cell types in which regulatory variants act. Results: We integrated a multi-ancestry GWAS of the ratio of forced expiratory volume in one second to forced vital capacity (FEV1/FVC; Shrine et al., n = 588,452) with single-cell lung eQTLs across 38 cell types (Natri et al., n = 114) by colocalization. We identified 20 candidate colocalizations (posterior probability of a shared causal variant > 0.7) for 13 genes in nine cell types, predominantly epithelial and immune. The two strongest signals localized DSP, an established COPD effector gene, and NRP2, a candidate effector gene, to alveolar type 2 epithelial cells; only these two colocalizations remained supported under a more conservative shared-effect prior. Both signals, together with FAM13A, were also detectable in bulk lung eQTLs, whereas most remaining loci colocalized only in the single-cell analysis. Conclusions: Single-cell eQTL colocalization resolves the alveolar epithelium as a cellular context for DSP and nominates NRP2 as a candidate lung function effector gene in the same compartment, highlighting the additional cellular resolution provided by single-cell data. The remaining candidate colocalizations warrant replication.
No takes yet. Share an insight, caveat, or question.
Eberle et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: